GP-Act III Acquisition Corp.
GPATFinancial ServicesNASDAQShell Companies · Last scanned Oct 26, 2026
Scan Results
Daily timeframeGP-Act III Acquisition Corp. does not have significant operations. Valued at $179.1M, GPAT is a micro-cap name in its sector. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Market Cap
$179.1M
Beta
-0.00
P/E (TTM)
44.32
P/E (Fwd)
—
EPS (TTM)
$0.25
EPS (Fwd)
—
ROE
—
ROA
-0.7%
Cash
$10,586
Total Debt
$596,313
Free CF
$236,482
52W Change
3.4%
Annual Financials
Cash vs Debt
Where GPAT stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, GPAT finished 1.37% above its 150-day moving average ($10.93) and 1.84% above its 200-day moving average ($10.88). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is GPAT overbought or oversold?
At the October 20, 2026 close, GPAT's RSI(14) was 58.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
GP-Act III Acquisition Corp. carries $596K in total debt against $11K in cash reserves — debt is roughly 56.3x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $236K in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing.
With a beta below 0.7, GP-Act III Acquisition Corp. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing GPAT.